These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9005137)

  • 1. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 1995.
    Eur J Nucl Med; 1996 Dec; 23(12):BP27-31. PubMed ID: 9005137
    [No Abstract]   [Full Text] [Related]  

  • 2. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 2000.
    Hesslewood SE
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):BP13-9. PubMed ID: 11976816
    [No Abstract]   [Full Text] [Related]  

  • 3. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 1999.
    Hesslewood SR
    Eur J Nucl Med; 2001 Feb; 28(2):BP2-8. PubMed ID: 11303900
    [No Abstract]   [Full Text] [Related]  

  • 4. [The 34th report on survey of the adverse reaction to radiopharmaceuticals (the 37th Survey in 2011)].
    Matsuda H; Arano Y; Okazawa H; Mizumura S; Yokoyama K; Yoshimura M; ; ;
    Kaku Igaku; 2013 Feb; 50(1):13-25. PubMed ID: 23700820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The 28th report on survey of the adverse reaction to radiopharmaceuticals (the 31st survey in 2005)].
    Kusakabe K; Arano Y; Okamura T; Kasagi K; Komatani A; Matsuda H; Maruno H; ; ;
    Kaku Igaku; 2007 Feb; 44(1):29-42. PubMed ID: 18240581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The 33rd report on survey of the adverse reaction to radiopharmaceuticals (the 36th Survey in 2010)].
    Matsuda H; Arano Y; Okazawa H; Okamura T; Mizumura S; Yokoyama K; ; ;
    Kaku Igaku; 2012 Feb; 49(1):1-14. PubMed ID: 22624452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The 35th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 38th Survey in 2012)].
    Matsuda H; Arano Y; Okazawa H; Mizumura S; Yokoyama K; Yoshimura M; ;
    Kaku Igaku; 2014 Feb; 51(1):1-12. PubMed ID: 24765821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of adverse reactions to radiopharmaceuticals in Europe.
    Hesslewood SR; Keeling DH
    Eur J Nucl Med; 1997 Sep; 24(9):1179-82. PubMed ID: 9283115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions to radiopharmaceuticals: the SNM/RSNA USP Drug Product Problem Reporting Program. Society of Nuclear Medicine/Radiological Society of North America. United States Pharmacopeial Convention.
    Silberstein EB
    J Nucl Med; 1997 Sep; 38(9):49N. PubMed ID: 9293782
    [No Abstract]   [Full Text] [Related]  

  • 10. [The 25th report on survey of the adverse reaction to radiopharmaceuticals (the 28th survey in 2002)].
    Kaku Igaku; 2004 Feb; 41(1):33-45. PubMed ID: 15171457
    [No Abstract]   [Full Text] [Related]  

  • 11. [The 27th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 30th survey in 2004)].
    Kusakabe K; Okamura T; Kasagi K; Komatani A; Sato Y; Matsuda H; Maruno H; ;
    Kaku Igaku; 2006 Feb; 43(1):23-35. PubMed ID: 16634540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The 26th report on survey of the adverse Reaction of radiopharmaceuticals (the 29th Survey in 2003)].
    Kaku Igaku; 2005 Feb; 42(1):33-45. PubMed ID: 15846875
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database.
    Laroche ML; Quelven I; Mazère J; Merle L
    Ann Pharmacother; 2015 Jan; 49(1):39-47. PubMed ID: 25366341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The 24th Report on Survey of the Adverse reaction to Radiopharmaceuticals (The 27th Survey in 2001)].
    Kaku Igaku; 2003 Feb; 40(1):39-50. PubMed ID: 12765188
    [No Abstract]   [Full Text] [Related]  

  • 15. The Twenty-Third Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 26th survey in 2000).
    Kusakabe K; Kasaki K; Kosuda S; Komaya A; Sato Y; Nishikawa J; Maruno H
    Kaku Igaku; 2002 Feb; 39(1):55-65. PubMed ID: 11936082
    [No Abstract]   [Full Text] [Related]  

  • 16. [The 41st Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 44th Survey in 2018)].
    ; Matsuda H; Uehara T; Okazawa H; Mizumura S; Yokoyama K; Yoshimura M
    Kaku Igaku; 2020; 57(1):11-21. PubMed ID: 32074551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions to radiopharmaceuticals: the RSNA-SNM-USP Drug Product Problem Reporting Program.
    Silberstein EB
    Radiology; 1997 Aug; 204(2):34A. PubMed ID: 9240510
    [No Abstract]   [Full Text] [Related]  

  • 18. [The twenty-first report on survey of the adverse reaction to radiopharmaceuticals (the 24th survey in 1998). Subcommittee of Safety Issue for the Radiopharmaceuticals. Medical and Pharmaceutical Committee. Japan Radioisotope Association].
    Kaku Igaku; 2000 May; 37(3):237-48. PubMed ID: 10860354
    [No Abstract]   [Full Text] [Related]  

  • 19. Surveillance of radiopharmaceuticals in Latin American: an alert.
    Santos-Oliveira R; Smith SW; de Souza Albernaz M; Bordim JA; Antunes LJ
    Rev Esp Med Nucl; 2011; 30(2):134-6. PubMed ID: 21334775
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacovigilance on the turn? Adverse reactions methods in 2012.
    Herxheimer A
    Int J Risk Saf Med; 2013 Jan; 25(1):29-31. PubMed ID: 23442295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.